Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Radiation Oncology (London, England)|March 29, 2018
TEDDI: radiotherapy delivery in deep inspiration for pediatric patients - a NOPHO feasibility studyAnni Young Lundgaard, Lisa Lyngsie Hjalgrim, Laura Ann Rechner, et al.Leukemia & Lymphoma|December 21, 2013
Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvementTarec Christoffer El-Galaly, Martin Hutchings, Karen Juul Mylam, et al.Scientific Reports|February 3, 2025
18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanomaTine Gadegaard Hindso, Torben Martinussen, Camilla Wium Bjerrum, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2016
Safety, Dosimetry, and Tumor Detection Ability of 68Ga-NOTA-AE105: First-in-Human Study of a Novel Radioligand for uPAR PET ImagingDorthe Skovgaard, Morten Persson, Malene Brandt-Larsen, et al.American Journal of Hematology|August 12, 2015
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish-Canadian study of 443 patients with diffuse-large B-cell lymphomaTarec Christoffer El-Galaly, Diego Villa, Musa Alzahrani, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 14, 2017
Whole-Body 18F-FDG PET/CT Is Superior to CT as First-Line Diagnostic Imaging in Patients Referred with Serious Nonspecific Symptoms or Signs of Cancer: A Randomized Prospective Study of 200 PatientsAnne-Mette Lebech, Anne Gaardsting, Annika Loft, et al.American Journal of Hematology|July 24, 2015
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patientsTarec Christoffer El-Galaly, Martin Bjerregård Pedersen, Martin Hutchings, et al.Thorax|December 21, 2010
Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trialBarbara M Fischer, Jann Mortensen, Hanne Hansen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2012
Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphomaTarec Christoffer El-Galaly, Francesco d'Amore, Karen Juul Mylam, et al.Acta Oncologica (Stockholm, Sweden)|June 10, 2021
Toward PET/MRI as one-stop shop for radiotherapy planning in cervical cancer patientsSahar Ahangari, Naja Liv Hansen, Anders Beck Olin, et al.Pageof 14